Review explores potential for improved use of anti-angiogenic agents in cancer therapy

FHS
August 9, 2024
11:39 pm

Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis.

Seven Big Problems With Hedge Funds — Especially for Doctors

In popular culture, hedge funds often get portrayed as the Holy Grail of investing. They are these secretive, exclusive, and not-well-understood entities that can invest

August 21, 2024

MD Anderson buys tech from Bellicum; Tarsus’ Lyme disease trial data; Rigel takes Gavreto

Plus, Ocular Therapeutix’s private placement, LimmaTech Biologics’ shigellosis vaccine data and a collaboration between Hox Therapeutics and Vernalis. MD Anderson buys tech from Bellicum: The Texas

February 23, 2024

10 insights to tackle vaccine hesitancy driven by misinformation on social media

Effective population level vaccination campaigns are fundamental to public health. Countercampaigns, which are as old as the first vaccines, can disrupt uptake and threaten public

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.